New Hope for Alzheimer's Patients: Sleeping Pill Reduces Tau Proteins by Up to 40%
2 Articles
2 Articles
A study shows that lemborexant, a common sleeping pill marketed as Dayvigo, appears to have a neuroprotective effect by limiting the toxic accumulation of tau protein – a major biomarker of neurodegenerative diseases such as Alzheimer's. This mechanism has reduced brain inflammation in laboratory mice, preserved the volume of their hippocampus, a key area in consolidating memories, while improving the quality of their sleep. In its physiological…
In almost every article about the brain, productivity, personal effectiveness and biohacking, I write about the fact that our body was and remains a universal system. And there are many factors and co-factors in the world that can affect the body in completely different ways. And it is no wonder that one specific drug can have several effects at once. Depending on the use. Tau proteins... The post New hope for Alzheimer's patients: sleeping pill…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage